Each capsule contains Proprietary Blend 400 mg: N-[2-hydroxy-2(4-methoxyphenyl) ethyl]-3-phenyl-2-propenamide , Citicoline . Other Ingredients: Modified Starch, Gelatin, Vegetable Stearate, Silicon Dioxide.
Brand name products often contain multiple ingredients. To read detailed information about each ingredient, click on the link for the individual ingredient shown above.
On October 11, 2013, the U.S. Food and Drug Administration (FDA) issued a warning letter to the manufacturer that this product is deemed to be adulterated because it contains a new dietary ingredient, aegeline, which lacks adequate information to provide reasonable assurance of safety. The manufacturer has failed to provide the FDA with evidence that this ingredient (also referred to as N-[2-hydroxy-2(4-methoxyphenyl) ethyl]-3-phenyl-2-propenamide) was safe for use in its dietary supplements (18946). The FDA findings also suggest that a causal connection may exist between the use of this product and a number of liver illnesses reported in Hawaii (18938). Advise patients not to take this product.
This product has been discontinued by the manufacturer.
Below is general information about the effectiveness of the known ingredients contained in the product VERSA-1. Some ingredients may not be listed. This information does NOT represent a recommendation for or a test of this specific product as a whole.
There is insufficient reliable information available about the effectiveness of aegeline.
INSUFFICIENT RELIABLE EVIDENCE to RATE
Below is general information about the safety of the known ingredients contained in the product VERSA-1. Some ingredients may not be listed. This information does NOT represent a recommendation for or a test of this specific product as a whole.
POSSIBLY UNSAFE ...when used orally. A specific product containing synthetic aegeline (Super Thermo OxyELITE Pro) has been associated with numerous case reports of liver toxicity and liver failure, some of which resulted in death (90904,102777,102779,102780). While other ingredients such as caffeine, yohimbine, and higenamine were also included in this product, these other ingredients have not been strongly implicated in hepatotoxicity (102781). Consequently, the liver injury associated with the product was attributed to aegeline. While the aegeline in this product was synthetic and may have included contaminants or toxic chemical derivatives (101520), evidence from feeding studies in rats has shown that the bael plant, which contains aegeline, can cause hepatic lesions (101521).
PREGNANCY AND LACTATION:
Insufficient reliable information is available; avoid using.
POSSIBLY SAFE ...when used orally and appropriately, short-term (12131). Citicoline 1000-2000 mg daily has been used with apparent safety for up to 12 weeks (12130,43248,98230,104828,109015,109016). Citicoline 2500 mg daily has also been used with apparent safety for up to 7 weeks (100988). ...when citicoline is used intravenously or intramuscularly under medical supervision (12131). Citicoline has been administered intravenously with apparent safety at a dose of 500 mg daily for 7 days, or 2000 mg daily for 3 days (43229,98444,104828). ...when used topically on the eye. Citicoline 2% eye drops have been used with apparent safety for up to 3 years alone or in combination with cyanocobalamin 0.05% (98229,104824,104825,104826,104827).
CHILDREN: POSSIBLY SAFE
when citicoline is used orally and appropriately.
Citicoline has been used with apparent safety for up to 1 year at a dose of 250 mg daily in children under 5 years of age and 500 mg daily in children 5-13 years of age (98442).
There is insufficient reliable information available about the safety of citicoline when used intravenously in children.
PREGNANCY AND LACTATION:
Insufficient reliable information available; avoid using.
Below is general information about the interactions of the known ingredients contained in the product VERSA-1. Some ingredients may not be listed. This information does NOT represent a recommendation for or a test of this specific product as a whole.
Aegeline inhibits cytochrome P450 3A4 (CYP3A4) activity in vitro (99300). So far, this interaction has not been reported in humans. Theoretically, aegeline may increase levels of drugs metabolized by CYP3A4. Some drugs metabolized by CYP3A4 include lovastatin (Mevacor), ketoconazole (Nizoral), itraconazole (Sporanox), fexofenadine (Allegra), triazolam (Halcion), and numerous others. Use aegeline cautiously or avoid in patients taking these drugs.
|
Below is general information about the adverse effects of the known ingredients contained in the product VERSA-1. Some ingredients may not be listed. This information does NOT represent a recommendation for or a test of this specific product as a whole.
General ...Orally, numerous cases of severe acute hepatitis, occasionally resulting in death, have been associated with use of a specific product containing synthetic aegeline (Super Thermo OxyELITE Pro) (90904,102777,102779,102780,102781).
Hepatic ...There are numerous case reports of severe acute hepatitis with fulminant liver failure associated with use of a specific multi-ingredient product containing aegeline (Super Thermo OxyELITE Pro). Symptoms included elevated liver enzymes, dark urine, jaundice, loss of appetite, nausea, abdominal pain, and fatigue. Onset of liver injury typically occurred in patients 2-20 weeks after beginning regular use of this product. Liver transplant was required in at least five cases, and there were at least two deaths (90904,101520,102777,102779,102780). The aegeline included in this product was synthesized by a Chinese manufacturer; the purity of this ingredient or whether it was identical to the constituent of the bael plant where it is found naturally is unclear (101520,102779). However, there is evidence from feeding trials in rats showing that the bael plant, which contains aegeline, can cause hepatic lesions (101521).
General
...Orally, intramuscularly, and intravenously, citicoline seems to be well-tolerated.
Most Common Adverse Effects:
Orally: Abdominal pain, back pain, blurred vision, constipation, diarrhea, edema, headache, insomnia, nausea, rash.
Cardiovascular ...Orally, citicoline may cause chest pain, palpitations, hypotension, bradycardia, tachycardia, and peripheral edema in some patients, although the incidence is likely similar to placebo (12130,12131,12132,43225).
Dermatologic ...Orally, citicoline may cause skin rash in some patients (12130,12132,43248).
Gastrointestinal ...Orally, citicoline may cause abdominal pain, constipation, diarrhea, and nausea in some patients (12130,12132,98846,100988,105730,109015).
Musculoskeletal ...Orally, citicoline may cause back pain in some patients (43225).
Neurologic/CNS ...Orally, citicoline may cause headache and insomnia in some patients (12130,43230,43273,98846,100988,109015,109016).
Ocular/Otic ...Orally, citicoline may cause blurred vision in some patients (12130,12132).
Other ...Orally, citicoline may cause edema of the extremities in some patients (43225).